| 000 | 01641 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515155149.0 | ||
| 264 | 0 | _c20090501 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/j.vaccine.2009.01.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchädlich, Lysann | |
| 245 | 0 | 0 |
_aRefining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. _h[electronic resource] |
| 260 |
_bVaccine _cMar 2009 |
||
| 300 |
_a1511-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 |
_aCapsid Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
| 650 | 0 | 4 |
_aEndotoxins _ximmunology |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman papillomavirus 16 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aOncogene Proteins, Viral _xgenetics |
| 650 | 0 | 4 |
_aPapillomavirus Infections _ximmunology |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _ximmunology |
| 700 | 1 | _aSenger, Tilo | |
| 700 | 1 | _aKirschning, Carsten J | |
| 700 | 1 | _aMüller, Martin | |
| 700 | 1 | _aGissmann, Lutz | |
| 773 | 0 |
_tVaccine _gvol. 27 _gno. 10 _gp. 1511-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2009.01.014 _zAvailable from publisher's website |
| 999 |
_c18620320 _d18620320 |
||